Effects of Gene Polymorphism After Transcranial Cranial Direct Current Stimulation on the Corticobulbar Excitability

November 5, 2019 updated by: Sun Im, The Catholic University of Korea

Role of Genetic Polymorphism in Neuroplasticity Involved in Dysphagia Recovery- Part 2

This study aims to examine the effects of transcranial direct current stimulation at corticobulbar excitability in individuals with different gene polymorphism.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The effects of TDCS on corticobulbar excitability of the brain after inhibitory pre-conditioning will be compared in patients with different BDNF phenotypes

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bucheonshi
      • Bucheon, Bucheonshi, Korea, Republic of
        • Department of Rehabilitation Medicine
    • Kyounggido
      • Bucheon, Kyounggido, Korea, Republic of
        • Department of Rehabilitation Medicine Bucheon St Mary's Hospital, Catholic University of Korea, College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy young volunteers

Description

Inclusion Criteria:

  • Age 19-40 years
  • Informed consent

Exclusion Criteria:

  • History of epilepsy
  • Presence of cardiac pacemaker
  • previous brain surgery
  • previous swallowing problems
  • current use of medication which acts on the central nervous system
  • presence of implanted metal intracranially

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy

Healthy adults

- Participants will receive single session of tdcs after application

application of optimised parameters of tDCS (anodal stimulation, 1.5 mA, 10 min) over the unconditioned hemisphere reverses the brain and behavioural consequences of inhibitory pre-conditioning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain corticobulbar excitability
Time Frame: Immediately after single conditioning the brain
Change of Brain corticobulbar excitability by motor evoked potentials
Immediately after single conditioning the brain

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tongue pressure measurement-
Time Frame: Immediate after single conditioning the brain
Change of tongue pressure measurement by Intra oral pressure assessment
Immediate after single conditioning the brain
Electrophysiological responses of swallowing -
Time Frame: Immediate after single conditioning the brain
Change of Electrophysiological responses of swallowing - With the use of a laryngeal transducer, will measure the mylohyoid amplitude
Immediate after single conditioning the brain

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sun Im, MD PhD, The Catholic University of Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2018

Primary Completion (Actual)

June 8, 2019

Study Completion (Actual)

August 8, 2019

Study Registration Dates

First Submitted

October 10, 2018

First Submitted That Met QC Criteria

October 17, 2018

First Posted (Actual)

October 19, 2018

Study Record Updates

Last Update Posted (Actual)

November 7, 2019

Last Update Submitted That Met QC Criteria

November 5, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HC18TNSV0061

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on tdcs

3
Subscribe